New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

Diabetes is a metabolic disorder that develops when the body is unable to produce or effectively use insulin the hormone ...

The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...